chr10-38117469-A-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001324250.3(ZNF37A):āc.318A>Cā(p.Glu106Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000156 in 1,609,568 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001324250.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF37A | NM_001324250.3 | c.318A>C | p.Glu106Asp | missense_variant | 8/8 | ENST00000685332.1 | NP_001311179.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF37A | ENST00000685332.1 | c.318A>C | p.Glu106Asp | missense_variant | 8/8 | NM_001324250.3 | ENSP00000508865.1 | |||
PLD5P1 | ENST00000640275.1 | n.238+2179A>C | intron_variant | 5 | ENSP00000491560.1 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152242Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000814 AC: 20AN: 245836Hom.: 0 AF XY: 0.0000677 AC XY: 9AN XY: 133020
GnomAD4 exome AF: 0.000161 AC: 235AN: 1457326Hom.: 0 Cov.: 34 AF XY: 0.000149 AC XY: 108AN XY: 724648
GnomAD4 genome AF: 0.000105 AC: 16AN: 152242Hom.: 0 Cov.: 33 AF XY: 0.0000538 AC XY: 4AN XY: 74376
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 20, 2024 | The c.318A>C (p.E106D) alteration is located in exon 8 (coding exon 4) of the ZNF37A gene. This alteration results from a A to C substitution at nucleotide position 318, causing the glutamic acid (E) at amino acid position 106 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at